Lupin gains US FDA approval for Tolvaptan tablets in various dosages, marking a significant entry into the nephrology market.

The USFDA inspection focused majorly on drug-device combination products, which is a niche but vital portion of the ...

Lupin’s injectable facility in Nagpur receives EIR from US FDA: Our Bureau, Mumbai Saturday, April 19, 2025, 13:40 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced ...

Tolvaptan is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic ...

Mumbai: Global pharma major, Lupin Limited, has received approval from the United States Food and Drug Administration (U.S.

Lupin receives USFDA approval for generic Tolvaptan tablets to treat kidney disease, launching soon with 180-day exclusivity.

Tolvaptan is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease.

The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril ...

Pharma major Lupin Ltd on Thursday said it has received approval from the US health regulator for its generic version of ...

Lupin receives USFDA approval for its generic version of Tolvaptan tablets, indicated for autosomal dominant polycystic ...